TRIM24
Overview
TRIM24 (TIF1A) is a transcriptional co-regulator with bromodomain and PHD finger domains. In the corpus, TRIM24 is identified as a 5’ fusion partner for BRAF in the tumor-agnostic BRAF fusion landscape.
Alterations observed in the corpus
- TRIM24 was identified as a 5’ fusion partner for BRAF among 82 unique partners across 52 histologies in a tumor-agnostic BRAF fusion cohort (MSK-IMPACT/MSK-Fusion) PMID:38922339.
- TRIM24–NTRK2 fusion identified in a lung ADC sample in a 1,144-NSCLC exome-sequencing cohort PMID:27158780.
Cancer types (linked)
- Not specifically linked to a single cancer type in the corpus; BRAF fusions involving TRIM24 were observed across diverse histologies PMID:38922339.
Co-occurrence and mutual exclusivity
- TRIM24-BRAF fusions co-occur with TP53 mutations (22% across all histologies) and other frequent co-alterations in BRAF fusion-positive tumors PMID:38922339.
Therapeutic relevance
- BRAF fusions are emerging actionable targets; MEK inhibitors (trametinib, selumetinib) and BRAF dimer blockers are under investigation PMID:38922339.
Open questions
- Clinical characteristics and response rates specific to TRIM24-BRAF fusions are not separately reported in the corpus PMID:38922339.
Sources
This page was processed by crosslinker on 2026-05-04. - PMID:27158780
This page was processed by wiki-cli on 2026-05-14.